State Of New Jersey Common Pension Fund D Global Blood Therapeutics, Inc. Transaction History

State Of New Jersey Common Pension Fund D

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	SELL	$32.4 - $68.18 $1.4 Million - $2.95 Million	-43,283 Reduced 53.47%	37,665 $2.57 Million
Q1 2022 May 03, 2022	SELL	$25.68 - $35.59 $217,509 - $301,447	-8,470 Reduced 9.47%	80,948 $2.8 Million
Q4 2021 Jan 31, 2022	SELL	$24.9 - $40.26 $309,556 - $500,512	-12,432 Reduced 12.21%	89,418 $2.62 Million
Q3 2021 Oct 27, 2021	BUY	$25.48 - $37.34 $896,259 - $1.31 Million	35,175 Added 52.76%	101,850 $2.6 Million
Q2 2021 Jul 23, 2021	BUY	$32.46 - $43.42 $558,571 - $747,171	17,208 Added 34.79%	66,675 $2.34 Million
Q1 2021 Apr 27, 2021	BUY	$38.94 - $50.85 $453,339 - $591,995	11,642 Added 30.78%	49,467 $2.02 Million
Q4 2020 Feb 03, 2021	SELL	$37.65 - $63.77 $102,031 - $172,816	-2,710 Reduced 6.69%	37,825 $1.64 Million
Q3 2020 Oct 27, 2020	BUY	$52.76 - $74.49 $45,848 - $64,731	869 Added 2.19%	40,535 $2.24 Million
Q2 2020 Aug 04, 2020	SELL	$48.73 - $81.82 $201,449 - $338,243	-4,134 Reduced 9.44%	39,666 $2.5 Million
Q3 2019 Oct 23, 2019	BUY	$45.35 - $57.91 $1.99 Million - $2.54 Million	43,800 New	43,800 $2.13 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.